Farringdon Capital, Ltd. Zoetis Inc. Transaction History
Farringdon Capital, Ltd.
- $393 Billion
- Q3 2025
A detailed history of Farringdon Capital, Ltd. transactions in Zoetis Inc. stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 4,166 shares of ZTS stock, worth $494,920. This represents 0.16% of its overall portfolio holdings.
Number of Shares
4,166
Previous 10,627
60.8%
Holding current value
$494,920
Previous $1.66 Billion
63.22%
% of portfolio
0.16%
Previous 0.56%
Shares
2 transactions
Others Institutions Holding ZTS
# of Institutions
2,089Shares Held
424MCall Options Held
1.82MPut Options Held
1.94M-
Vanguard Group Inc Valley Forge, PA42.3MShares$5.03 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$4.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.6MShares$2.33 Billion0.1% of portfolio
-
Morgan Stanley New York, NY16.9MShares$2.01 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL15.9MShares$1.89 Billion1.96% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $55.6B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...